MARK1
Basic information
Region (hg38): 1:220528136-220664461
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MARK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 27 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 4 | 2 |
Variants in MARK1
This is a list of pathogenic ClinVar variants found in the MARK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-220528866-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
1-220579426-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
1-220579453-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
1-220579483-C-T | not specified | Uncertain significance (Jun 21, 2022) | ||
1-220579541-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
1-220579549-G-C | not specified | Uncertain significance (Feb 14, 2023) | ||
1-220616013-ATT-A | Benign (Nov 16, 2023) | |||
1-220618363-T-C | Likely benign (May 16, 2018) | |||
1-220618433-G-A | not specified | Uncertain significance (Jul 26, 2023) | ||
1-220618490-G-A | not specified | Uncertain significance (Jun 21, 2021) | ||
1-220618528-C-T | Likely benign (Apr 24, 2018) | |||
1-220618649-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
1-220618669-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
1-220618682-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
1-220618694-A-T | not specified | Uncertain significance (Jan 16, 2024) | ||
1-220631117-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
1-220632245-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
1-220635393-G-A | Likely benign (Feb 01, 2023) | |||
1-220635425-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
1-220635836-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
1-220635855-T-C | Likely benign (Jun 29, 2018) | |||
1-220635953-T-C | not specified | Uncertain significance (May 31, 2023) | ||
1-220650683-G-T | not specified | Uncertain significance (Apr 18, 2023) | ||
1-220650692-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
1-220652005-A-G | not specified | Uncertain significance (Dec 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MARK1 | protein_coding | protein_coding | ENST00000366917 | 18 | 136236 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.600 | 0.400 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.73 | 289 | 452 | 0.639 | 0.0000252 | 5192 |
Missense in Polyphen | 73 | 187.57 | 0.38918 | 2168 | ||
Synonymous | 1.87 | 127 | 157 | 0.810 | 0.00000850 | 1525 |
Loss of Function | 4.98 | 10 | 46.7 | 0.214 | 0.00000313 | 509 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000186 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2 and MAP4. Phosphorylates the microtubule- associated protein MAPT/TAU (PubMed:23666762). Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:17573348, ECO:0000269|PubMed:23666762}.;
- Disease
- DISEASE: Note=Genetic variations in MARK1 may be associated with susceptibility to autism. MARK1 is overexpressed in the prefrontal cortex of patients with autism and causes changes in the function of cortical dendrites.;
- Pathway
- WNT-Ncore;Regulation of Microtubule Cytoskeleton
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.503
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 31.93
Haploinsufficiency Scores
- pHI
- 0.454
- hipred
- Y
- hipred_score
- 0.750
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.920
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mark1
- Phenotype
Gene ontology
- Biological process
- microtubule cytoskeleton organization;neuron migration;protein phosphorylation;cytoskeleton organization;regulation of neuron projection development;Wnt signaling pathway;peptidyl-serine phosphorylation;establishment of cell polarity;intracellular signal transduction;regulation of dendrite development;establishment of mitochondrion localization
- Cellular component
- cytoplasm;cytoskeleton;plasma membrane;microtubule cytoskeleton;dendrite
- Molecular function
- magnesium ion binding;phosphatidylserine binding;protein serine/threonine kinase activity;protein binding;ATP binding;phosphatidylinositol-4,5-bisphosphate binding;tau protein binding;tau-protein kinase activity;phosphatidic acid binding